Sharon Klier

Company: Oculis Operations Sarl

Job title: Senior Vice President & Chief Development Officer

Seminars:

Driving forward Phase 3 DIAMOND trials of OCS-01 eye drops, a topical OPTIREACH formulation of high-concentration dexamethasone for DME 11:00 am

Highlighting the OPTIREACH formulation technology and associated benefits Discussing remaining unmet medical needs for DME patient management Exploring the clinical evidence to date on the efficacy and safety of OCS-01 eye drops for DME Read more

day: Conference Day One